We are live on
!
Find out more
WC
Woodstock Corp Portfolio holdings
AUM
$1.2B
1-Year Est. Return
26.37%
This Fund
S&P 500
This Quarter
Est. Return
-0.43%
1 Year Est. Return
+26.37%
3 Year Est. Return
+96.13%
5 Year Est. Return
+140.78%
10 Year Est. Return
+511.59%
AUM
$531M
AUM Growth
-$8.26M
(-1.5%)
Cap. Flow
-$3.36M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
23%
Holding
170
New
2
Increased
45
Reduced
60
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$1.47M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$846K |
| 3 |
United Natural Foods
UNFI
|
+$832K |
| 4 |
SWI
SOLARWINDS INC COM STK (DE)
SWI
|
+$463K |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$454K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Karyopharm Therapeutics
KPTI
|
+$1.19M |
| 2 |
ExxonMobil
XOM
|
+$585K |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$500K |
| 4 |
Procter & Gamble
PG
|
+$494K |
| 5 |
CDK
CDK Global, Inc.
CDK
|
+$466K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.94% |
| 2 | Technology | 13.75% |
| 3 | Industrials | 12.06% |
| 4 | Consumer Staples | 10.11% |
| 5 | Energy | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
O'Reilly Automotive
ORLY
$75.9B
| $14.3M | 2.7% |
950,520
-1,950
| -0.2% | -$28.9K |
|
2
CVS Health
CVS
$123B
| $14.2M | 2.67% |
134,978
-3,560
| -3% | -$364K |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $12.4M | 2.34% |
107,186
-2,431
| -2% | -$278K |
|
4
Microsoft
MSFT
$3.69T
| $12.2M | 2.3% |
276,359
-2,065
| -0.7% | -$94.2K |
|
5
GE Aerospace
GE
$390B
| $12.1M | 2.29% |
95,240
-3,344
| -3% | -$434K |
|
6
PepsiCo
PEP
$188B
| $11.6M | 2.19% |
124,714
-1,610
| -1% | -$154K |
|
|
APC
7
DELISTED
Anadarko Petroleum
APC
| $11.4M | 2.15% |
146,376
+300
| +0.2% | +$26K |
|
|
8
ExxonMobil
XOM
$632B
| $11.3M | 2.14% |
136,180
-6,800
| -5% | -$585K |
|
9
Johnson & Johnson
JNJ
$617B
| $11.3M | 2.13% |
115,784
-4,525
| -4% | -$453K |
|
10
Oracle
ORCL
$417B
| $11.2M | 2.1% |
277,072
-2,805
| -1% | -$122K |
|
|
11
Procter & Gamble
PG
$342B
| $10.7M | 2.02% |
137,337
-6,140
| -4% | -$494K |
|
12
Medtronic
MDT
$110B
| $9.98M | 1.88% |
134,631
-1,367
| -1% | -$104K |
|
13
State Street
STT
$51.3B
| $9.86M | 1.86% |
128,005
-900
| -0.7% | -$70.1K |
|
14
Home Depot
HD
$349B
| $9.8M | 1.85% |
88,193
-50
| -0.1% | -$5.6K |
|
15
Alphabet (Google) Class C
GOOG
$4.39T
| $9.2M | 1.73% |
347,660
+3,578
| +1% | +$95.9K |
|
16
Kinder Morgan
KMI
$69.5B
| $8.61M | 1.62% |
224,186
+950
| +0.4% | +$39.7K |
|
17
Ecolab
ECL
$79.3B
| $8.55M | 1.61% |
75,608
-455
| -0.6% | -$52.3K |
|
18
RTX Corp
RTX
$298B
| $8.48M | 1.6% |
121,455
+1,049
| +0.9% | +$77K |
|
19
Apple
AAPL
$4.53T
| $8.2M | 1.54% |
261,356
-1,280
| -0.5% | -$40.9K |
|
20
3M
MMM
$92.9B
| $8.18M | 1.54% |
63,368
+1,998
| +3% | +$268K |
|
21
Verizon
VZ
$194B
| $8.17M | 1.54% |
175,349
+1,641
| +0.9% | +$80.3K |
|
22
Walt Disney
DIS
$180B
| $8.06M | 1.52% |
70,660
+97
| +0.1% | +$10.7K |
|
23
AbbVie
ABBV
$430B
| $7.9M | 1.49% |
117,552
+1,755
| +2% | +$115K |
|
24
Merck
MRK
$317B
| $7.84M | 1.48% |
144,272
+1,258
| +0.9% | +$70.6K |
|
|
HBI
25
DELISTED
Hanesbrands
HBI
| $7.83M | 1.48% |
234,920
-750
| -0.3% | -$24.5K |
|
Similar funds
VC
FCCPG
MB
AIM
TIM
SC
CS
CCM
Woodstock Corp's Q2 2015 Portfolio in Review
As of Q2 2015, Woodstock Corp held 170 positions worth $531M, down 1.5% from $539M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Woodstock Corp's Q2 2015 filing shows 2 new, 45 increased, 60 reduced and 7 closed positions. Its largest new stake was Neurocrine Biosciences: 19,955 shares worth $953K. The largest sale was Karyopharm Therapeutics, an estimated $1.19M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.
- Woodstock Corp's largest Q2 2015 buy was Neurocrine Biosciences: 19,955 shares worth $953K.
- Woodstock Corp added most to Southwestern Energy Company in Q2 2015, an estimated $1.47M increase.
- Woodstock Corp's biggest Q2 2015 reduction was ExxonMobil, cutting an estimated $585K.
- Woodstock Corp fully exited Karyopharm Therapeutics in Q2 2015, selling an estimated $1.19M.
- Woodstock Corp's ten largest holdings make up 23% of its $531M portfolio in Q2 2015.
- Woodstock Corp opened 2 new positions and closed 7 in Q2 2015.
- Woodstock Corp's portfolio value fell 1.5% quarter-over-quarter to $531M.
Based on Woodstock Corp's 13F filing for Q2 2015, filed 7 Jul 2015.